Kentucky Retirement Systems Insurance Trust Fund Has $2.62 Million Holdings in Zoetis Inc. (NYSE:ZTS)

Kentucky Retirement Systems Insurance Trust Fund decreased its holdings in Zoetis Inc. (NYSE:ZTS) by 8.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,414 shares of the company’s stock after selling 1,303 shares during the period. Kentucky Retirement Systems Insurance Trust Fund’s holdings in Zoetis were worth $2,621,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the stock. Intech Investment Management LLC grew its position in Zoetis by 94.6% in the first quarter. Intech Investment Management LLC now owns 2,320 shares of the company’s stock worth $393,000 after acquiring an additional 1,128 shares in the last quarter. Acadian Asset Management LLC lifted its position in shares of Zoetis by 49.6% in the first quarter. Acadian Asset Management LLC now owns 25,051 shares of the company’s stock worth $4,235,000 after buying an additional 8,302 shares during the last quarter. Jacobi Capital Management LLC increased its holdings in shares of Zoetis by 1.5% during the 1st quarter. Jacobi Capital Management LLC now owns 8,161 shares of the company’s stock valued at $1,381,000 after acquiring an additional 121 shares during the last quarter. Catalytic Wealth RIA LLC raised its stake in shares of Zoetis by 7.5% in the 1st quarter. Catalytic Wealth RIA LLC now owns 4,107 shares of the company’s stock valued at $695,000 after acquiring an additional 285 shares in the last quarter. Finally, Beaumont Financial Advisors LLC lifted its holdings in Zoetis by 31.1% in the 1st quarter. Beaumont Financial Advisors LLC now owns 1,855 shares of the company’s stock worth $314,000 after purchasing an additional 440 shares during the last quarter. 92.80% of the stock is owned by hedge funds and other institutional investors.

Zoetis Trading Up 0.3 %

Zoetis stock opened at $175.14 on Friday. The business has a 50 day moving average price of $187.09 and a two-hundred day moving average price of $180.23. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $201.92. The stock has a market cap of $79.02 billion, a price-to-earnings ratio of 32.92, a price-to-earnings-growth ratio of 2.69 and a beta of 0.90.

Zoetis (NYSE:ZTS) last issued its earnings results on Monday, November 4th. The company reported $1.58 EPS for the quarter, beating analysts’ consensus estimates of $1.46 by $0.12. The business had revenue of $2.40 billion during the quarter, compared to analyst estimates of $2.29 billion. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. Zoetis’s revenue was up 11.6% on a year-over-year basis. During the same period in the prior year, the company posted $1.36 earnings per share. As a group, equities analysts forecast that Zoetis Inc. will post 5.9 EPS for the current year.

Zoetis Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 3rd. Investors of record on Thursday, October 31st will be given a $0.432 dividend. This represents a $1.73 annualized dividend and a yield of 0.99%. The ex-dividend date of this dividend is Thursday, October 31st. Zoetis’s dividend payout ratio (DPR) is presently 32.52%.

Analyst Ratings Changes

ZTS has been the topic of a number of recent analyst reports. BTIG Research lifted their price target on shares of Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research report on Monday, August 12th. Stifel Nicolaus upped their price target on shares of Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a report on Wednesday, September 18th. JPMorgan Chase & Co. lifted their price objective on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Piper Sandler increased their target price on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, August 14th. Finally, Argus raised Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Ten investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $221.44.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.